The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNcc Regulatory News (NCC)

Share Price Information for Ncc (NCC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 136.00
Bid: 135.60
Ask: 136.20
Change: 1.60 (1.19%)
Spread: 0.60 (0.442%)
Open: 133.80
High: 136.00
Low: 131.40
Prev. Close: 134.40
NCC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

24 Mar 2017 16:00

RNS Number : 5180A
NCC Group PLC
24 March 2017
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

NCC Group plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

Aviva plc & its subsidiaries

4. Full name of shareholder(s)  (if different from 3.):iv

Registered Holder:

 

Chase (GA Group) Nominees Limited 1,747,831*

 

Chase Nominees Limited 66,028*

 

HSBC Global Custody Nominee (UK) Limited 66,750*

 

State Street Nominees Limited 289,488*

* denotes direct interest

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

23 March 2017

6. Date on which issuer notified:

24 March 2017

7. Threshold(s) that is/are crossed orreached: vi, vii

3% to

 

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary Shares

GB00B01QGK86

 

 

 

11,003,348*

 

 

 

11,003,348*

 

 

 

2,170,097

 

 

 

2,170,097

 

 

 

Below Threshold **

 

 

 

0.79%

 

 

 

Below Threshold **

 

* Includes Right to recall loaned shares (7,929,552)

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

RIGHT TO RECALL LOANED SHARES

N/A

N/A

 

6,094,488*

 

*Direct interest

 

2.20%

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

Nominal

Delta

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

8,264,585

2.99%

 

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

The voting rights are managed and controlled by Aviva Investors Global Services Limited, with the following chain of controlled undertakings:-

 

Aviva Investors Global Services Limited:

· Aviva plc (Parent Company)

· Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc)

· Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited)

· Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited)

 

Proxy Voting:

10. Name of the proxy holder:

See Section 4

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

 

 

13. Additional information:

Figures are based on the total number of voting rights of 276,490,207, as per the Company's Total Voting Rights Announcement of 28 February 2017.

 

** Although not reportable, as per DTR5.1.5,the non-disclosable (indirect) position is currently 832,356 shares, and is included here in the interests of transparency.

 

14. Contact name:

Neil Whittaker, Aviva plc

15. Contact telephone number:

 01603 684420

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLLLFEEVTISFID
Date   Source Headline
18th Jul 20235:14 pmRNSDirector/PDMR Shareholding
4th Jul 20231:19 pmRNSDirector/PDMR Shareholding
27th Jun 20237:00 amRNSDirector/PDMR Shareholding
22nd Jun 20237:00 amRNSUnaudited Post-Close Trading and Strategy Update
8th Jun 20237:00 amRNSNotice of Trading Update
31st May 20232:32 pmRNSTotal Voting Rights
18th May 20239:57 amRNSBlock Listing Application
4th May 20231:36 pmRNSHolding(s) in Company
26th Apr 202311:48 amRNSHolding(s) in Company
25th Apr 20237:00 amRNSAppointment: Director of Strategy & Transformation
19th Apr 20233:17 pmRNSDirector/PDMR Shareholding
4th Apr 20232:24 pmRNSHolding(s) in Company
31st Mar 20235:00 pmRNSHolding(s) in Company
31st Mar 20237:00 amRNSTrading update
9th Mar 20232:54 pmRNSNCC Group announces HEAnet cyber partnership
28th Feb 20232:41 pmRNSTotal Voting Rights
15th Feb 20234:06 pmRNSHolding(s) in Company
14th Feb 20237:00 amRNSNCC Group joins Amazon Web Services Marketplace
10th Feb 202310:16 amRNSNCC Group Annual Threat Monitor Report
2nd Feb 20237:00 amRNSUnaudited Interim results period ended 30/11/2022
31st Jan 20233:00 pmRNSBlock listing Interim Review
31st Jan 20233:00 pmRNSTotal Voting Rights
30th Dec 20221:30 pmRNSTotal Voting Rights
20th Dec 20227:00 amRNSNew facilities to fund future strategy and growth
7th Dec 202211:30 amRNSBlock listing Interim Review
30th Nov 20223:30 pmRNSTotal Voting Rights
4th Nov 20225:14 pmRNSDirector/PDMR Shareholding
2nd Nov 20224:41 pmRNSDirector/PDMR Shareholding
2nd Nov 20223:50 pmRNSResult of AGM
2nd Nov 20227:00 amRNSAGM Trading Statement
1st Nov 202212:00 pmRNSDirector/PDMR Shareholding
31st Oct 20223:00 pmRNSTotal Voting Rights
31st Oct 202211:27 amRNSDirector/PDMR Shareholding
31st Oct 202211:25 amRNSDirector/PDMR Shareholding
26th Oct 202210:04 amRNSDirector/PDMR Shareholding
25th Oct 20222:35 pmRNSHolding(s) in Company
21st Oct 20229:56 amRNSDirector/PDMR Shareholding
18th Oct 20224:10 pmRNSDirector/PDMR Shareholding
12th Oct 20223:51 pmRNSDirector/PDMR Shareholding
10th Oct 20222:52 pmRNSDirector/PDMR Shareholding
10th Oct 20222:49 pmRNSDirector/PDMR Shareholding
4th Oct 20223:38 pmRNSHolding(s) in Company
30th Sep 20222:00 pmRNSTotal Voting Rights
22nd Sep 20229:00 amRNSNotice of AGM
16th Sep 20224:57 pmRNSHolding(s) in Company
16th Sep 20229:35 amRNSDirector/PDMR Shareholding
6th Sep 20227:00 amRNSPreliminary results for the year ended 31 May 2022
31st Aug 20222:30 pmRNSTotal Voting Rights
29th Jul 20222:05 pmRNSBlock listing Interim Review
29th Jul 20222:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.